Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH) The study was approved by the ...

OAK BROOK, Ill. - Women with mammographically detected breast lesions that are probably benign should have follow-up surveillance imaging at six months due to the small but not insignificant risk that ...

Based on data from a multi-site imaging trial involving more than 2,600 women, researchers say breast lesions categorized as 'probably benign' on supplemental screening ultrasound could be ...

While this test can’t medically diagnose breast cancer, it can help identify anything abnormal. Not all abnormal findings are considered cancerous. Doctors use the BI-RADS system to place abnormal ...